[
    [
        {
            "time": "",
            "orginal_text": "上海医药(02607.HK)将派发末期股息每10股4.1元",
            "features": {
                "keywords": [
                    "上海医药",
                    "末期股息",
                    "派发"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "上海医药(02607.HK)将派发末期股息每10股4.1元",
            "scores": {
                "News_content": "上海医药(02607.HK)将派发末期股息每10股4.1元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "上海医药(02607.HK)推选徐有利担任监事长",
            "features": {
                "keywords": [
                    "上海医药",
                    "监事长",
                    "徐有利"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "上海医药(02607.HK)推选徐有利担任监事长",
            "scores": {
                "News_content": "上海医药(02607.HK)推选徐有利担任监事长",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "中国“科”公司之药明康德：中国医药行业的黄埔军校",
            "features": {
                "keywords": [
                    "药明康德",
                    "医药行业",
                    "黄埔军校"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "中国“科”公司之药明康德：中国医药行业的黄埔军校",
            "scores": {
                "News_content": "中国“科”公司之药明康德：中国医药行业的黄埔军校",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]